The Indian Council of Medical Research (ICMR) reported 100 successful technology-transfer deals at its 2026 health research summit. The reported outcomes include 20 licensing agreements covering eight technologies with nine Indian companies. The development illustrates how publicly supported biomedical research can move from laboratories towards practical use.
Key figures to remember
- 100 successful technology-transfer deals reported.
- 20 licensing agreements.
- Eight technologies covered by the reported licensing agreements.
- Nine Indian companies involved in those agreements.
- 17 technologies showcased at the event.
- More than 600 attendees were reported.
What is technology transfer?
Technology transfer is the process through which knowledge, inventions, methods or technologies developed by a research institution are made available to another organisation for further development, production, commercialisation or use. It may involve licensing intellectual property, technical know-how, materials, training and collaboration.
In health research, the process can help translate laboratory findings into diagnostics, vaccines, devices, therapeutics, testing platforms and public-health tools. A successful transfer still requires validation, regulatory compliance, manufacturing quality, affordability and evidence of real-world performance.
ICMR and the Department of Health Research
ICMR is India’s apex body for the formulation, coordination and promotion of biomedical research. It functions under the Department of Health Research, Ministry of Health and Family Welfare. Its work spans basic, applied and operational health research, disease surveillance, research capacity and collaboration with academic and industry partners.
Why the reported outcomes matter
Research institutions often face a gap between discovery and deployment. Licensing and industry partnerships can help bridge this gap by bringing manufacturing expertise, investment, supply-chain capability and market access. For India, stronger domestic translation of health research can support preparedness, innovation and access to locally relevant technologies.
What should be assessed beyond deal numbers?
- Whether the technology has completed appropriate scientific and clinical validation.
- Whether regulatory approvals are in place where required.
- Whether production can meet quality and scale requirements.
- Whether the final product is affordable and accessible.
- Whether the technology addresses a meaningful public-health need.
Competitive-exam relevance
For UPSC GS-III and science and technology papers, connect technology transfer with innovation ecosystems, public-funded research, intellectual property rights, public-private partnerships, health security and Atmanirbhar Bharat. For general science, revise the roles of ICMR, DHR and the Ministry of Health and Family Welfare.
Practice questions
- ICMR functions under which department? Department of Health Research.
- Technology transfer primarily helps bridge which gap? The gap between research and practical application or commercialisation.
- How many licensing agreements were reported in the summit figures? 20.
Official sources
For institutional information and research updates, consult ICMR, the Department of Health Research and the Press Information Bureau.


